ITMI910359A0 - Impiego medicamentoso di derivati diidropiridinici - Google Patents

Impiego medicamentoso di derivati diidropiridinici

Info

Publication number
ITMI910359A0
ITMI910359A0 IT91MI359A ITMI910359A ITMI910359A0 IT MI910359 A0 ITMI910359 A0 IT MI910359A0 IT 91MI359 A IT91MI359 A IT 91MI359A IT MI910359 A ITMI910359 A IT MI910359A IT MI910359 A0 ITMI910359 A0 IT MI910359A0
Authority
IT
Italy
Prior art keywords
medicinal use
dihydropyridine derivatives
dihydropyridine
derivatives
medicinal
Prior art date
Application number
IT91MI359A
Other languages
English (en)
Inventor
Giovanni Gaviraghi
Luciano Aimi
Original Assignee
Glaxo Spa
Glaxo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa, Glaxo filed Critical Glaxo Spa
Publication of ITMI910359A0 publication Critical patent/ITMI910359A0/it
Priority to ITMI910359A priority Critical patent/IT1244728B/it
Priority to ES92102146T priority patent/ES2106098T3/es
Priority to AT92102146T priority patent/ATE157004T1/de
Priority to CS931650A priority patent/CZ281760B6/cs
Priority to DE69221649T priority patent/DE69221649T2/de
Priority to DK92102146.5T priority patent/DK0499920T3/da
Priority to PCT/EP1992/000276 priority patent/WO1992014460A1/en
Priority to SG1996007490A priority patent/SG59972A1/en
Priority to EP92102146A priority patent/EP0499920B1/en
Priority to AU12231/92A priority patent/AU646929B2/en
Priority to US08/094,150 priority patent/US5455257A/en
Priority to UA93004263A priority patent/UA27780C2/uk
Priority to JP4503957A priority patent/JP2996725B2/ja
Priority to RU93054780A priority patent/RU2136279C1/ru
Priority to EP92903946A priority patent/EP0576433A1/en
Priority to CA002103805A priority patent/CA2103805C/en
Priority to MX9200600A priority patent/MX9200600A/es
Priority to ZA921006A priority patent/ZA921006B/xx
Priority to IL10092892A priority patent/IL100928A/xx
Priority to IE045392A priority patent/IE920453A1/en
Priority to PH43915A priority patent/PH30130A/en
Publication of ITMI910359A1 publication Critical patent/ITMI910359A1/it
Priority to KR1019930702402A priority patent/KR100188171B1/ko
Priority to NO932874A priority patent/NO303713B1/no
Application granted granted Critical
Publication of IT1244728B publication Critical patent/IT1244728B/it
Priority to GR970402303T priority patent/GR3024661T3/el
Priority to HK98110314A priority patent/HK1009585A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ITMI910359A 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici IT1244728B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici
JP4503957A JP2996725B2 (ja) 1991-02-13 1992-02-08 動脈硬化の治療のためのラシジピンの使用
EP92903946A EP0576433A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
CS931650A CZ281760B6 (cs) 1991-02-13 1992-02-08 Použití diethylesteru kyseliny (E)-4-/2-/3-(1,1-dimethylethosy)-3-oxo-1-propenyl/fenyl/-1,4-dihydr o-2,6-dimethyl-3,5-pyridindikarboxylové pro výrobu farmaceutických prostředků pro léčení nebo....
DE69221649T DE69221649T2 (de) 1991-02-13 1992-02-08 Lacidipin zur Behandlung der Arteriosklerosis
DK92102146.5T DK0499920T3 (da) 1991-02-13 1992-02-08 Lacidipin til behandling af arteriosclerosis
PCT/EP1992/000276 WO1992014460A1 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
SG1996007490A SG59972A1 (en) 1991-02-13 1992-02-08 Medicaments
EP92102146A EP0499920B1 (en) 1991-02-13 1992-02-08 Lacidipine for the treatment of arteriosclerosis
AU12231/92A AU646929B2 (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
US08/094,150 US5455257A (en) 1991-02-13 1992-02-08 Lacidipine for the treatment of arteriosclerosis
UA93004263A UA27780C2 (uk) 1991-02-13 1992-02-08 Діюча речовина лікарського засобу для лікування або профілактики артеріосклерозу та/або асоційованих з ним серцево-судинних захворювань, спосіб лікування або профілактики артеріосклерозу у ссавців та лікарський засіб, що в ньому використовується
ES92102146T ES2106098T3 (es) 1991-02-13 1992-02-08 Lacidipino para el tratamiento de la arteriosclerosis.
RU93054780A RU2136279C1 (ru) 1991-02-13 1992-02-08 Применение лацидипина для лечения артериосклероза
AT92102146T ATE157004T1 (de) 1991-02-13 1992-02-08 Lacidipin zur behandlung der arteriosklerosis
CA002103805A CA2103805C (en) 1991-02-13 1992-02-08 Use of lacidipine for the treatment of arteriosclerosis
MX9200600A MX9200600A (es) 1991-02-13 1992-02-12 Medicamento que contiene lacidipina, para el tratamiento o prevencion de arteriosclerosis.
ZA921006A ZA921006B (en) 1991-02-13 1992-02-12 Medicaments
IL10092892A IL100928A (en) 1991-02-13 1992-02-12 Use of lacidipine for the preparation of pharmaceutical compositions for the treatment and/or prevention of arteriosclerosis
IE045392A IE920453A1 (en) 1991-02-13 1992-02-12 Medicaments
PH43915A PH30130A (en) 1991-02-13 1992-02-12 Lacidipine for the treatment of arteriosclerosis
KR1019930702402A KR100188171B1 (en) 1991-02-13 1993-08-12 Use of lacidipine for the treatment of arteriosclerosis
NO932874A NO303713B1 (no) 1991-02-13 1993-08-12 Anvendelse av lacidipin for behandling av arteriosklerose
GR970402303T GR3024661T3 (en) 1991-02-13 1997-09-09 Lacidipine for the treatment of arteriosclerosis
HK98110314A HK1009585A1 (en) 1991-02-13 1998-08-31 Lacidipine for the treatment of arteriosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Publications (3)

Publication Number Publication Date
ITMI910359A0 true ITMI910359A0 (it) 1991-02-13
ITMI910359A1 ITMI910359A1 (it) 1992-08-13
IT1244728B IT1244728B (it) 1994-08-08

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Country Status (24)

Country Link
US (1) US5455257A (it)
EP (2) EP0499920B1 (it)
JP (1) JP2996725B2 (it)
KR (1) KR100188171B1 (it)
AT (1) ATE157004T1 (it)
AU (1) AU646929B2 (it)
CA (1) CA2103805C (it)
CZ (1) CZ281760B6 (it)
DE (1) DE69221649T2 (it)
DK (1) DK0499920T3 (it)
ES (1) ES2106098T3 (it)
GR (1) GR3024661T3 (it)
HK (1) HK1009585A1 (it)
IE (1) IE920453A1 (it)
IL (1) IL100928A (it)
IT (1) IT1244728B (it)
MX (1) MX9200600A (it)
NO (1) NO303713B1 (it)
PH (1) PH30130A (it)
RU (1) RU2136279C1 (it)
SG (1) SG59972A1 (it)
UA (1) UA27780C2 (it)
WO (1) WO1992014460A1 (it)
ZA (1) ZA921006B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1868577A4 (en) * 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
HK1009585A1 (en) 1999-06-04
GR3024661T3 (en) 1997-12-31
IE920453A1 (en) 1992-08-12
EP0499920A1 (en) 1992-08-26
WO1992014460A1 (en) 1992-09-03
ATE157004T1 (de) 1997-09-15
MX9200600A (es) 1992-10-30
SG59972A1 (en) 1999-02-22
CZ281760B6 (cs) 1997-01-15
CA2103805C (en) 2002-09-17
DE69221649T2 (de) 1997-12-11
NO932874L (no) 1993-08-12
US5455257A (en) 1995-10-03
DK0499920T3 (da) 1998-01-26
EP0499920B1 (en) 1997-08-20
UA27780C2 (uk) 2000-10-16
ITMI910359A1 (it) 1992-08-13
IL100928A (en) 1997-02-18
JPH06505002A (ja) 1994-06-09
ZA921006B (en) 1992-12-30
DE69221649D1 (de) 1997-09-25
JP2996725B2 (ja) 2000-01-11
NO932874D0 (no) 1993-08-12
PH30130A (en) 1997-01-21
KR100188171B1 (en) 1999-06-01
IT1244728B (it) 1994-08-08
ES2106098T3 (es) 1997-11-01
CZ165093A3 (en) 1994-03-16
RU2136279C1 (ru) 1999-09-10
NO303713B1 (no) 1998-08-24
CA2103805A1 (en) 1992-08-14
AU1223192A (en) 1992-09-15
EP0576433A1 (en) 1994-01-05
AU646929B2 (en) 1994-03-10

Similar Documents

Publication Publication Date Title
FI934914A (fi) Farmaceutiska formuleringar
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
IT8848619A0 (it) Derivati di lisosfingolipidi
ITMI910303A1 (it) Derivati della 5-oxo-l-prolina e loro applicazioni farmaceutiche
ITMI920408A1 (it) Derivati benzopiranici e benzotiopiranici
BR9200058A (pt) Composto e composicao farmaceutica
IT1252567B (it) Derivati di 5-isochinolinsolfonammidi inibitori delle protein-chinasi
ITTO920719A1 (it) Derivati benzopiranici
MX9200622A (es) Composicion farmaceutica
ITMI910080A1 (it) Derivati arilvinilamidici e procedimento per la loro preparazione
ITPD910139A0 (it) Nuovi derivati di gangliosidi
DE69024843D1 (de) Rhodanin-Derivate und pharmazeutische Zusammensetzungen
IT8848618A0 (it) Derivati di lisogangliosidi
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
ITMI910359A0 (it) Impiego medicamentoso di derivati diidropiridinici
KR950702115A (ko) 디히드로피리딘 유도체의 신규 의약 용도(novel medicinal use of dihydropyridine derivative)
ITMI920884A0 (it) Derivati del flavone
IT1242214B (it) Derivati polifunzionali delle ciclodestrine
ITMI913434A1 (it) Derivati di tetraidro-5-isochinolinsolfonammidi
FI941681A0 (fi) Tioformamidijohdannaiset
ITRM920060A0 (it) Xenocollagene e derivati a61
ITMI911863A0 (it) Derivati di idroisochinolina
ITMI911862A0 (it) Derivati di idroisochinolina
ITMI931727A0 (it) Derivati di 5-isochinolinsolfonammidi

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227